meglumine has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arruda, D; Foss, NT; Motta, AC; Souza, CS | 1 |
| Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M | 1 |
2 other study(ies) available for meglumine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompromised Host; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2003 |
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Hypotension; Immunocompromised Host; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2005 |